Syntax Bio
Programming new cell therapies using CRISPR-based technology.
Programming new cell therapies using CRISPR-based technology. Headquartered in Chicago, IL. Raised $14.4M in Series A funding in June 2026 led by Astellas Venture Management.
Biotechnology
📍 Chicago, IL
Founded 2026
Current Valuation
Private
PRIVATE
IPO Outlookprivate
Is Syntax Bio going public?
No. Syntax Bio is private and has not filed to go public. There is no S-1 on file.
What is Syntax Bio's valuation in 2026?
No confirmed valuation is on record for Syntax Bio. The roster shows funding and investors where they are public; it does not estimate a mark.
Has Syntax Bio filed an S-1?
No public S-1 is on file for Syntax Bio.
Who are Syntax Bio's investors?
Syntax Bio's investors include Astellas Venture Management, Illumina Ventures, DCVC Bio, Civilization Ventures, EGB Capital, Mansueto Office and 6 more.
How much has Syntax Bio raised?
Syntax Bio has raised $25M in total across 1 disclosed round, most recently a Series A of $14.4M in Jun 2026.
Is Syntax Bio publicly traded — can you buy Syntax Bio stock?
No. Syntax Bio is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Syntax Bio on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Last Round
Series A — $14.4M (Jun 2026) · Lead: Astellas Venture Management
Fundraising Status
Series A · $14.4M · 3 mo ago
privateTotal raised $25M1 disclosed rounds
Funding History
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Series A | $14.4M | Jun 2026 | Astellas Venture Management | — |
Vertical Intelligence — Biotech / Gene Therapy
No name-verified sponsor record on ClinicalTrials.gov for Syntax Bio — trials may run under a different legal entity, a partner sponsor, or not yet exist. Absence of a registry match is reported as-is, never guessed around.
Checked clinicaltrials.gov as of 2026-09-19. Re-checked weekly.
Talent Signal
No public careers page or job board could be found for Syntax Bio as of 2026-09-14. That itself is a datapoint: no open external hiring surface.
Checked the company site and major hosted job boards. Re-checked monthly.
Investors
Astellas Venture Management · Illumina Ventures · DCVC Bio · Civilization Ventures · EGB Capital · Mansueto Office · Portal Innovations · Draper Associates · Allegis Capital · LongGame · Mayo Clinic · Illinois Ventures
BiotechnologySynthetic BiologyRecently Funded
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.